Registered number: 02339750
Charity number: 801382
(FORMERLY KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD)
(A company limited by guarantee)
UNAUDITED
TRUSTEES' REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
CONTENTS
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 1
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
The Trustees present their annual report together with the financial statements of the company for the 1 January 2025 to 31 December 2025. The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).
Since the company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
Objectives and activities
a. Policies and objectives
The charity is governed by its Memorandum and Articles of Association and aims to promote the relief of persons in the county of Kent who live with Multiple Sclerosis (MS) and other neurological conditions by any lawful means and in particular and without prejudice to the generality of the foregoing:
∙to provide advice, guidance and moral and practical support for persons living with MS
∙to provide therapy (including oxygen therapy) for persons living with MS or other similar symptoms or conditions
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.
b. Activities for achieving objectives
The charitable company administers and equips a centre for the provision of therapies. "Active" members are required to pay for membership to the centre, thereafter full members are asked for a donation contributing to the operating costs/cost of therapy and associate members are required to pay a fixed charge albeit one well below the market rate. The centre also raises funds through events and donations.
The major source of funds comes from the enormous support that the charity receives from Trusts and Foundations without whom the centre would not exist.
There have been no material changes in these policies since the last report.
Page 2
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
Achievements and performance
a. Review of activities
The charitable company has continued its main objective of providing a range of therapies, support and advice to those with MS, their families and carers. The Centre continues to provide a state of the art facility to its users and consequently the principal therapies of Physiotherapy & Hydrotherapy (and associated gym and classes), Complementary Therapies, Podiatry, Acupuncture and High Dose Oxygen Therapy have all remained in strong demand.
The Centre also continues to treat a range of non MS conditions with High Dose Oxygen Therapy including some life long conditions such as fibromyalgia, cancer, post operative wounds and sports injuries, the income from which assists in the subsidising of its services to members with MS.
In 2025 MS members were consulted regarding the integration of membership which would see stroke and Parkinson’s users having equal access to the Centre and all 3 groups becoming neuro members. Furthermore a name change to the Kent Neuro Therapy Centre was proposed. On 11 September 2025 at an Extraordinary General Meeting, Members voted yes to these changes. From 1 January 2026 the Kent MS Therapy Centre will be rebranded and known as the Kent Neuro Therapy Centre and those living with MS, Parkinson’s and Stroke survivors will have equal membership rights.
In 2025 the 3 year strategy – Towards 2027: Growing Stronger Together was published with all staff aligned to the objectives identified.
Continual investment in Centre staff and facilities has further strengthened the offering available to Centre users, in particular development of the Clinical team (physiotherapy) and associated therapy spaces.
As at the end of 2025 the Charity served 409 MS members and 311 Associate members (a total of 720 members). Forty seven of these members had experienced a stroke and 19 lived with Parkinson’s. In terms of our direct beneficiaries, 632 individuals used one or more of our therapies and activities in 2025 (560 in 2024). Together, they attended 13,493 times.
At the start of 2025 the Centre experienced significant water damage on the ground floor due to a flood. This was as a result of a corroded pipe in the Oxygen wing toilet. All damage was repaired, fixtures and fittings replaced where necessary. This was covered by our buildings and contents insurance.
The Trustees wish to record their grateful thanks to our volunteers and others who willingly donate their time and services to our cause. Their wonderful support ensures that the centre continues to provide care and support to members and will continue to do so for the foreseeable future.
The Trustees would like the extend a specific thank you to the Frank Brake Charitable Trust, the William Brake Charitable Trust, Sport England, Clothworkers’ Foundation, Sir Jules Thorn Charitable Trust, Roger de Haan Charitable Trust, Canterbury City Council RISE, the Souter Charitable Trust, the Meads Trust, Screwfix Foundation, The Loveday Charitable Trust and the Edward Gostling Foundation.
The Centre also continues to treat a range of non MS conditions with High Dose Oxygen Therapy including some life long conditions such as fibromyalgia, cancer, post operative wounds and sports injuries, the income from which assists in the subsidising of its services to members with MS.
In 2025 MS members were consulted regarding the integration of membership which would see stroke and Parkinson’s users having equal access to the Centre and all 3 groups becoming neuro members. Furthermore a name change to the Kent Neuro Therapy Centre was proposed. On 11 September 2025 at an Extraordinary General Meeting, Members voted yes to these changes. From 1 January 2026 the Kent MS Therapy Centre will be rebranded and known as the Kent Neuro Therapy Centre and those living with MS, Parkinson’s and Stroke survivors will have equal membership rights.
In 2025 the 3 year strategy – Towards 2027: Growing Stronger Together was published with all staff aligned to the objectives identified.
Continual investment in Centre staff and facilities has further strengthened the offering available to Centre users, in particular development of the Clinical team (physiotherapy) and associated therapy spaces.
As at the end of 2025 the Charity served 409 MS members and 311 Associate members (a total of 720 members). Forty seven of these members had experienced a stroke and 19 lived with Parkinson’s. In terms of our direct beneficiaries, 632 individuals used one or more of our therapies and activities in 2025 (560 in 2024). Together, they attended 13,493 times.
At the start of 2025 the Centre experienced significant water damage on the ground floor due to a flood. This was as a result of a corroded pipe in the Oxygen wing toilet. All damage was repaired, fixtures and fittings replaced where necessary. This was covered by our buildings and contents insurance.
The Trustees wish to record their grateful thanks to our volunteers and others who willingly donate their time and services to our cause. Their wonderful support ensures that the centre continues to provide care and support to members and will continue to do so for the foreseeable future.
The Trustees would like the extend a specific thank you to the Frank Brake Charitable Trust, the William Brake Charitable Trust, Sport England, Clothworkers’ Foundation, Sir Jules Thorn Charitable Trust, Roger de Haan Charitable Trust, Canterbury City Council RISE, the Souter Charitable Trust, the Meads Trust, Screwfix Foundation, The Loveday Charitable Trust and the Edward Gostling Foundation.
b. Public awareness
The Trustees and the Senior Leadership Team continue to promote awareness of the Centre within the local community.
Page 3
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
Achievements and performance (continued)
c. Public benefit
The Trustees have complied with their duty to have regard to the guidance on public benefit published by the Charity Commission in exercising their powers or duties.
The activities of the charity are directed to providing significant support for those with MS and other similar conditions both through treatment and therapy, informal advice and peer support.
Any contribution made towards the running costs of the charity is at the discretion of the member with MS and all MS Members have the opportunity to benefit from the activities of the charity without charge. The balance of the running cost is subsidised through its fundraising and income generation activities.
The activities of the charity are directed to providing significant support for those with MS and other similar conditions both through treatment and therapy, informal advice and peer support.
Any contribution made towards the running costs of the charity is at the discretion of the member with MS and all MS Members have the opportunity to benefit from the activities of the charity without charge. The balance of the running cost is subsidised through its fundraising and income generation activities.
d. Achievements and performance overview
Kent Neuro Therapy Centre continues to extend the scope of therapies on offer. In 2025, the charity delivered a total of 13,493 sessions of therapy. A summary is shown below.
* This is the total distinct members over all therapies. A member may have accessed multiple therapies but that person will only be counted once in the total distinct count. Therefore the sum of the distinct attendees will not equal the distinct total.
As we attract more Members with MS and extend our therapy offering the level of subsidy required to support our therapies increases. Fundraising and sustainable income generation becomes ever more important.
e. Fundraising and income generation
Page 4
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
Achievements and performance (continued)
Financial review
a. Going concern
b. Reserves policy
General review
Incoming resources for the year amounted to £782,143 (2024 - £857,831) with expenditure totalling £799,494 (2024 - £764,029) resulting in a deficit of £17,351 (2024 - a surplus of £93,802).
It is the Trustees intention to apply all funds received in any one year whilst maintaining an appropriate level of unrestricted reserves in accordance with the policy.
The charity is grateful to its staff, therapists and volunteers who have assisted with income generating activities.
Restricted funds for specific projects have been received during the year from the following sources:
Structure, governance and management
Page 5
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
Structure, governance and management (continued)
a. Constitution
The company is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association on 5 March 1993. The company is a registered charity, number 801382.
The principal object of the company is the provision of services and support to aid and improve the condition of those living with Multiple Sclerosis.
The principal object of the company is the provision of services and support to aid and improve the condition of those living with Multiple Sclerosis.
b. Methods of appointment or election of Trustees
c. Organisational structure and decision-making policies
d. Risk management
The Trustees have assessed the major risks to which the company is exposed, those related to the operations and finances of the company and are satisfied that systems and procedures are in place to mitigate exposure to the major risks.
The support we have had from our donors and sponsors has been unparalleled and very much appreciated; the centre remains in reasonable financial health considering the challenges imposed on fund raising.
We remain confident as Trustees that the centre will continue to improve and grow to better support the lives of people living with MS in Kent.
The support we have had from our donors and sponsors has been unparalleled and very much appreciated; the centre remains in reasonable financial health considering the challenges imposed on fund raising.
We remain confident as Trustees that the centre will continue to improve and grow to better support the lives of people living with MS in Kent.
Future developments
Our strategy Towards 2027: Growing Stronger Together is built on four pillars:
1. Our Priorities
2. Member Experience
3. Our Way
4. Our Team
Together with their teams, the leadership team have achieved all objectives set for 2025 in each of the 4 pillars.
Collaboration with Canterbury Christ Church University continues to strengthen, in particular with regards to student placements which include Physiotherapy and Occupational Therapy.
The Centre has been identified as 1 of 4 data collection sites for the national Refuel MS study which is being led by King’s College London and support by the NIHR and MS Society. Relevant clinical staff will be trained to assist in the delivery of this study.
Page 6
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
Our Mission
"Improving the lives of those living with MS in Kent"
The Centre aims to radically improve the lives of those with Multiple Sclerosis, their families and those who care for them.
We aim to:
1. Provide a range of complementary therapies and specialist clinics,
2. Give advice, support and information to those living with MS, their carers and families, in an
environment which encourages mutual support and friendship,
3. Be a Centre of Excellence which enables self-management of the condition,
4. Welcome people throughout Kent.
The Centre aims to radically improve the lives of those with Multiple Sclerosis, their families and those who care for them.
We aim to:
1. Provide a range of complementary therapies and specialist clinics,
2. Give advice, support and information to those living with MS, their carers and families, in an
environment which encourages mutual support and friendship,
3. Be a Centre of Excellence which enables self-management of the condition,
4. Welcome people throughout Kent.
Statement of Trustees' responsibilities
Approved by order of the members of the board of Trustees and signed on their behalf by:
Page 7
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
I report to the charity Trustees on my examination of the accounts of the company for the year ended 31 December 2025.
As the Trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Since the company's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the company's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the company's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the company's Trustees as a body, for my work or for this report.
Signed: Dated: 17 August 2026
Roland Parry FCA
Magee Gammon
Chartered Accountants
Page 8
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 9
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
REGISTERED NUMBER: 02339750
BALANCE SHEET
AS AT 31 DECEMBER 2025
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
Page 10
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 11
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
The Kent Neuro Therapy Centre Limited is a private company, limited by guarantee, incorporated in England and Wales. The company registration number is 02339750.
The registered office address is Bradbury House, Merton Lane (North), Canterbury, Kent, CT4 7DZ.
The registered office address is Bradbury House, Merton Lane (North), Canterbury, Kent, CT4 7DZ.
2.Accounting policies
All income is recognised once the company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the company has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the company, can be reliably measured.
Grants are included in the Statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.
Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.
Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service.
Page 12
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
Tangible fixed assets costing £NIL or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.
Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, as below.
Depreciation is provided on the following basis:
Page 13
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
The company operates a defined contribution pension scheme and the pension charge represents the amounts payable by the company to the fund in respect of the year.
Page 14
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 15
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 16
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 17
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 18
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
10.Analysis of expenditure by activities (continued)
Analysis of direct costs (continued)
Page 19
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 20
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 21
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Financial assets measured at fair value through income and expenditure comprise of cash at bank and in hand.
Page 22
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 23
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 24
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 25
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 26
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 27
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
21.Analysis of net assets between funds (continued)
Page 28
KENT NEURO THERAPY CENTRE LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
The charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the charity in an independently administered fund. The pension cost charge represents contributions payable by the charity to the fund and amounted to £8,324 (2024 - £7,537). Contributions totalling £nil (2024 - £nil) were payable to the fund at the balance sheet date and are included in creditors.
Each member of the charitable company undertakes to contribute to the assets of the company in the event of it being wound up while they are a member, or within one year after they cease to be a member, such amount as may be required, not exceeding £1 for the debts and liabilities contracted before they cease to be a member.
Page 29